Perioperative Opioid Use in Urogynecologic Mesh Removal.

ABSTRACT:

Importance

Forty percent of patients with urogynecologic mesh pain complications are taking narcotics.

Objectives

We aimed to compare comorbidities and pain scores between patients with and without narcotic use and assess postoperative narcotic use rates.

Study design

This was a secondary analysis of a prospective cohort study of patients undergoing urogynecologic mesh removal. Patients with mesh removal for pain within 7 years were included due to data availability. Narcotic prescriptions were verified using the Pennsylvania Prescription Drug Monitoring Program. Pain scores were assessed at baseline and 6-24 months postoperatively.

Results

Of 139 patients, 30 (21.6%) filled narcotic prescriptions within 3 months preceding surgery. These patients were younger a

SUBMITTER: Artsen AM 

PROVIDER: S-EPMC11658796 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature